Developing IEC Standard Practice Guidelines across Settings

In 2016, a Comprehensive Cancer Center opened an ambulatory cellular immunotherapy clinic, partnered with an inpatient facility for hospitalization. The center provides FDA Approved CAR T Cell therapies as well investigational immune effector cell (IEC) products under Phase I/II clinical trials. To optimize patient care, a multidisciplinary workgroup developed IEC specific standard of care guidelines. These standards facilitate alignment of care between sites and promotes collaboration between nurses and providers to enhance patient outcomes.

Source: Biology of Blood and Marrow Transplantation - January 24, 2020 Category: Hematology Authors: Anne Reese, Merav Bar, Lenise Taylor, Angela Kirk Tags: 600 Source Type: research